two new biotech drugs for colorectal cancer, Avastin and Erbitux

March 2004

You might hear about two new biotech drugs for colorectal cancer, Avastin and Erbitux.

They just got approved in the U.S...investigational in Canada.

Avastin (bevacizumab) is the first angiogenesis inhibitor. It's plowing new ground for the new crop of cancer drugs that slow the growth of new blood vessels that tumours need to grow.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

pharmacists will be providing pharmaceutical care
Infectious Diseases Valtrex for decreasing heterosexual transmission of genital herpes
Infectious Diseases best time to give varicella vaccine
Adderall XR, the new once-daily capsule for ADHD
new guidelines for monitoring patients on atypical antipsychotics
Less than HALF of the people carrying epinephrine auto-injectors know when or how to use them properly
Women's Health heart disease should be treated in WOMEN just as aggressively as it's treated in MEN
Ophthalmology confusion between Acular and the new Acular LS eyedrops
Ophthalmology what to use for allergic conjunctivitis
The FDA and Health Canada are forcing manufacturers to get away from ephedra
potential interaction between warfarin and glucosamine-chondroitin supplements
Hematology & Oncology two new biotech drugs for colorectal cancer, Avastin and Erbitux
Hematology & Oncology whether antibiotics increase the risk of breast cancer
Osteoporosis strontium for bone loss
Bird flu is causing quite a flap

two new biotech drugs for colorectal cancer, Avastin and Erbitux

Practical advice for a better career, with unlimited access to CE

Table of Contents